...and they got some really good news tonight.
http://www.bizjournals.com/sanfrancisco/blog/biotech/2011/08/neuraltus-als-lou-gehrig.html?s=print
By Ron Leuty in the San Francisco Business Times
Neuraltus ALS drug wins FDA orphan and fast-track status!
Now to fill the few remaining seats in the trial so that we can see how fast the fast-track is.
No comments:
Post a Comment